Bradley S. Galer is EVP & Chief Medical Officer of ZOGENIX, INC.. Currently has a direct ownership of 0 shares of ZGNX, which is worth approximately $0. The most recent transaction as insider was on Mar 07, 2022, when has been sold 25,022 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Bradley S. Galer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2022
SELL
Disposition due to a tender of shares in a change of control transaction
-
25,022 Reduced 100.0%
0 Common Stock
Mar 15 2021
SELL
Payment of exercise price or tax liability
$30,263 $20.7 p/Share
1,462 Reduced 6.28%
21,803 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
-
5,218 Added 18.99%
22,258 Common Stock

Also insider at

RAPP
Rapport Therapeutics, Inc.
BSG

Bradley S. Galer

EVP & Chief Medical Officer
Emeryville, CA

Track Institutional and Insider Activities on ZGNX

Follow ZOGENIX, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZGNX shares.

Notify only if

Insider Trading

Get notified when an Zogenix, Inc. insider buys or sells ZGNX shares.

Notify only if

News

Receive news related to ZOGENIX, INC.

Track Activities on ZGNX